Recognition modes of individual T-cell receptors (TCR) are well studied, but how TCR repertoires are selected during acute through persistent human virus infections is less clear. Here, we show that persistent EBV-specific clonotypes account for only 9% of unique clonotypes but are highly expanded in acute infectious mononucleosis, and have distinct antigen-specific public features that drive selection into convalescence. The other 91% of highly diverse unique clonotypes disappear and are replaced in convalescence by equally diverse "de-novo" clonotypes. These broad fluctuating repertoires lend plasticity to antigen recognition and potentially protect against T-cell clonal loss and viral escape. 
Introduction
Over 95% of the world's population is persistently infected with Epstein Barr virus (EBV) by the fourth decade of life. Primary infection commonly occurs in young childhood and is asymptomatic or only mildly symptomatic; primary infection in late childhood or early adulthood often results in acute infectious mononucleosis (AIM) 1 , which is associated with an increased risk of subsequent multiple sclerosis (MS) 2 or Hodgkin's lymphoma 3 .
EBV infection is also associated with Burkitt lymphoma, nasopharyngeal cancer, hairy leukoplakia in individuals with AIDS, and lymphoproliferative malignancies in transplant patients 3, 4 . EBV-associated post-transplant lymphoproliferative disorders can be prevented or treated by adoptive transfer of EBV-specific CD8 T-cells [4] [5] [6] . Altogether, these data indicate that EBV-specific CD8 T-cells are important for viral control 7 .
Defective CD8 T-cell control of EBV reactivation may also result in the expansion of
EBV-infected, autoreactive B cells in multiple sclerosis (MS)
; improvement of MS has followed infusion of autologous EBV-specific CD8 T-cells 2 . Improved T-cell therapies would benefit from insights derived from approaches that integrate computational biology and structural modeling to predict optimum TCR features and identify TCR antigen-specificity groups [9] [10] [11] [12] [13] [14] . These methods need to be based on an accurate and in depth understanding of antigen-specific TCR repertoire structure and organization from studies like the one presented here. Ultimately, this could lead to better understanding of how EBV-specific CD8 T-cells control EBV replication and facilitate the development of a vaccine to prevent or immunotherapies to modify EBV infection 5, 6, 15 .
One of the hallmarks of CD8 T-cells is epitope-specificity, conferred by the interaction of the TCR with virus-derived peptides bound to host MHC (pMHC) [16] [17] [18] [19] . The TCR is a membrane-bound, heterodimeric protein composed of . This diversity enables CD8 T-cell responses to a myriad of pathogens.
The CD8 TCR repertoire is an important determinant of CD8 T-cell-mediated antiviral efficacy or immune-mediated pathology 14, 21, [23] [24] [25] [26] . Defining the relationships between early and memory CD8 TCR repertoires is important to understanding structural features of the TCR repertoire that govern the selection and persistence of CD8 T-cells into memory. Deep sequencing techniques, combined with structural analyses, provide a high throughput and unbiased approach to understanding antigen-specific TCRαβ repertoires. We 27 and others [28] [29] [30] [31] have recently reported that TCRαβ repertoires of CD8
T-cell responses to common viruses (influenza, cytomegalovirus, hepatitis C virus) are highly diverse and individualized (i.e. "private") but "public" clonotypes (defined as the same V, J, or CDR3 aa sequences in many individuals) are favored for expansion, likely due to selection for optimal structural interactions.
To thoroughly evaluate molecular features of TCR that are important for driving repertoire selection over time following EBV infection, we used direct ex vivo deep sequencing of TCR Vα and Vβ regions, along with paired TCR Vα/β single-cell sequencing of CD8 T-cells specific to two immunodominant epitopes, GLC and YVL, isolated from peripheral blood during primary EBV infection (AIM) and 6 months later in convalescence (CONV). Each TCR repertoire had a high degree of diversity. However, clonotypes that persisted from AIM to CONV, had distinct public features driving their selection, which was dependent on the specific antigen; while these persistent clonotypes accounted for only 9% of the unique clonotypes, they predominated in both the acute and convalescent phases of infection. The corollary of this finding was that 91% of the unique clonotypes expanded in acute infection were replaced in 6 months by an equally diverse set of de novo clonotypes.
Results

Patient characteristics:
Four HLA-A*02:01+ individuals presenting with symptoms of AIM and laboratory studies consistent with primary infection were studied (Table S1 ) at initial clinical presentation (AIM) and 6-8 months later (Convalescence; CONV)). Direct tetramer staining of peripheral blood revealed that 2.7%±0.7 (mean+SEM) and 1.3%±0.3 of CD8 T-cells were YVL-and GLC-specific, and declined to 0.3%±0.7 and 0.3%±0.1, respectively, in CONV. Mean blood EBV load was 3.9±0.7 log 10 and 1.7±1.0 log 10 genome copies/10 6 B cells during AIM and CONV, respectively.
Deep sequencing reveals a high level of TCR diversity and epitope-specific
features that drive selection of the TCR repertoire: To examine features that drive selection of YVL-and GLC-specific TCRs in AIM and CONV, deep sequencing of TCRα and β repertoires was conducted directly ex vivo on tetramer-sorted CD8 T cells at both time points (Fig 1-2 , S1-2, Table S2 ). The characteristics of the TCR repertoires for each of 3 donors were elucidated by systematically analyzing preferential VA or VB usage hierarchy as presented in pie charts, CDR3 length analyses, VJ pairing by circos plots, and dominant CDR3 motif; the latter determines if there was enrichment of particular aa residues at specific sites important for ligand interaction. Enrichment for certain characteristics would suggest that these features are important for pMHC interaction and selection of the TCR repertoire 9,27,32-35
. YVL-and GLC-specific CD8 TCR repertoires in AIM demonstrated inter-individual differences, and were highly diverse;
the mean (±SD) number of unique clonotypes were not significantly different in CONV (YVL: AIM TCRα 5548±2118, TCRβ 9038±3208; CONV TCRα 2981±940, TCRβ 3899±626; GLC: AIM TCRα 4202±1782, TCRβ 4540±1028; CONV TCRα 3982±848, TCRβ 4964±1139). However, there was a pronounced bias toward particular VA and VB gene family usage, specific to each epitope, that was maintained from AIM into CONV.
The 9-mer TCRα AV8.1-VKDTDK-AJ34 drives selection of YVL-specific CD8 Tcells:
The YVL-specific TCR AV repertoire was focused on one dominant family, AV8, used by all donors in AIM and CONV (Fig 1Ai, S1AAi) . Similar strong selection bias was not observed in YVL-specific BV usage; there was a great deal of inter-individual variation and preferential usage of multiple families, including BV6, BV20, BV28, BV29 (Fig 1Bi, S1ABi) . However, in CONV some V gene families that dominated in AIM became extinct or subdominant, or new dominant genes emerged. For example, in CONV, E1655's YVL TCR repertoire, AV8, BV6, and BV11 became subdominant while BV3 in E1603 and AV17 in E1655 became dominant (Fig 1Ai, Bi) . In AIM, CDR3α length distribution varied from 9 to 14 aa; 9-and 11-mers represented 50% of all clonotypes (Fig S1AAii) . Circos plot analysis of the 9-mer clonotypes showed that the dominant AV8.1 gene almost exclusively paired with AJ34 (Fig S1AAiii) . CDR3α motif analysis revealed a pronounced motif, "VKDTDK", in these shorter 9-mer clonotypes, representing 13.8%±5.6 of the total CD8 T-cell response during acute AIM (Fig 1Aiii, S1AAiv, Table S3A ); 87%±1.7 of the clonotypes using this motif were AV8.1 and 92%±1.7 were AJ34. Interestingly, this motif was present in multiple other AV and AJ pairs, including AV12, AV21 and AV3 among the most common. The fact that a dominant AV8.1 response obligately paired to AJ34 containing a highly conserved motif was observed in all donors from AIM through CONV, suggests that 9-mer AV8.1-VKDTDK-AJ34 expressing clones were highly selected by HLA-A2/YVL. The YVL CDR3β length varied, with 11-and 13-me representing 60% of clonotypes. There was a preferential usage of BV20-BJ2.7 pairing within the 11-mer response (Fig 1Bii,   S1ABiii ) without a CDR3β motif (Fig 1Biii, S1ABiv) , highlighting a great degree of diversity in the aa composition. Within the 13-mer response (Fig 1Biii,S1ABiv , Table   S3B ), the CDR3β motif, "LLGG", was commonly used. This motif arose predominantly from BV28-BJ1 pairing (donor E1603, E1632) or BV6-BJ2 pairing (E1655). Clonotypes with this motif were only a minor part of overall responses in 2 donors (E1603, E1655), but composed 17.4% of the total YVL TCR BV repertoire in E1632. Altogether, these results suggest that the 9-mer AV8.1-VKDTDK-AJ34 expressing clones were highly preferentially selected by YVL ligand during AIM and CONV and that this AV chain could pair with multiple different BV chains.
AV5-EDNNA-AJ31, BV14-SQSPGG-BJ2, and BV20-SARD-BJ1 are dominant selection factors for GLC-specific CD8 T-cells: The pattern of GLC-specific AV and BV usage had clear preference for particular gene families, consistent with prior reports 36, 37 , that was maintained from AIM into CONV. We observed apparent preferential use of public AV5, 12, and BV20, 14, 9, 28, 29 families (Fig 2Ai, Bi, S1BAi, Bi). There were differences in preferential usage of CDR3 lengths between the two epitopes. For instance, the AIM YVL-specific repertoire used more of the shorter 10-mer CDR3β than GLC in both AIM and CONV (Fig 3Aii) . Like YVL, there were some individual changes in the transition into CONV with AV20 becoming extinct in E1603;
AV19 emerging as dominant in E1632 (Fig 2Ai) . In AIM, clonotypes with 9-and 11-mer CDR3α lengths represented 70% of the total response, while clonotypes with longer 11-and 13-mer CDR3β lengths represented 65% of total response (Fig S1BAii, S1BBii) .
Circos plot analysis of the 9-mer CDR3α length clonotypes revealed a conserved and dominant AV5-AJ31 pairing in all 3 donors (Fig S1BAiii) . A prominent motif, "EDNNA", was identified within 9-mer clonotypes, of which 85%±11 were associated with AV5-AJ31 (Fig 2Aiii, S1BAiv , Table S3C ). This AV CDR3α motif was used by only 2.8%±1.7 of all clonotypes recognizing GLC in the 3 donors. The AV12 family dominated the 11-mer response, including AV12.1, AV12.2 and AV12.3 usage pairing with multiple different AJ genes depending on the donor. The 11-mer CDR3β BV14-BJ2 pairing exhibited a conserved, previously reported public motif, "SQSPGG"
38
, which
represented 26% and 40% of the total GLC-specific response in donors E1632 and E1655 in AIM, respectively (Fig S1BBii-iv, Table S3D ). Within the CDR3β 13-mer responses, a conserved BV20-BJ1 pairing, including the previously reported public motif, "SARD", was used by all 3 donors, and represented 11%±6 of the total GLCspecific response (Fig 2Biii, S1BBii -iv, Table S3E ). Within the 13-mer CDR3β response, there was also a consensus motif, "SPTSG" present in all 3 donors, which was used by multiple different BV families, which represented 20% and 2% of the total response in donors E1632 and E1655, respectively in AIM (Fig 2Bii-iv , Table S3E ).
These data suggest that, in contrast to YVL whose TCR-repertoire selection was primarily driven by AV chain usage, the selection of GLC-specific TCR-repertoire in AIM was driven by a combination of both AV and BV chain usage.
CDR3 lengths are a major factor in the selection of the GLC-and YVL-specific TCR repertoires: The changing pattern of the epitope-specific TCR AV or BV family use from AIM to CONV for both epitope specific responses was also reflected by some changes in dominant CDR3 lengths (Fig 3) . For example, the frequencies of the longer GLC-specific 12-mer CDR3 α and β clonotypes significantly increased from 13.6±6%
and 6±2.8%, respectively, in AIM to 24±5% and 17.9±8%, respectively, in CONV; while use of the shorter 11-mer CDR3α decreased (Fig 3Ai-ii) . Within the YVL response usage of the shorter 9-mer CDR3α also decreased. Despite these changes, the factors that were identified in AIM to drive the selection of YVL-or GLC-specific CD8 T-cells were conserved in CONV, retaining the same dominant V gene families and CDR3
1 0 motifs indicating the strength of these TCR features in driving selection of the repertoire (Fig 1-2 , Table S3 ).
To address whether clonotypes that persisted into memory show similar characteristics to those that dominate in acute infection, YVL and GLC TCRα/β repertoires were compared between AIM and CONV. Each unique TCRα or TCRβ clonotype (defined as a unique DNA rearrangement) elicited during AIM that was also detected during CONV was defined as a "persistent" clonotype. Clonotypes were regarded as "non-persistent"
or "de novo" if they were present only during AIM or CONV, respectively. A high level of TCR diversity was maintained from AIM to CONV; however, the overlap between the number of unique clonotypes detected during AIM and CONV was small (Fig 4Ai, Bi) .
Only a small fraction, 6.6±2.2 -9.1±4.2% of the TCRα/β YVL-and GLC-specific unique clonotypes, respectively, present in AIM were maintained at 8.7±4.9 -18.5±5.6% during CONV. However, they comprised 57.5±26.2 -75.5±12% of the total response when including their frequency (sequence reads) in AIM and 35.8±10.2 -55.8±13.4% in CONV. While the clonotypic composition of GLC-and YVL-specific CD8 T-cells changed over the course of primary infection, dominant TCR clonotypes detected during AIM tended to persist and dominated in CONV. Altogether, these data indicate that persistent clonotypes made up only a small percentage of unique clonotypes but were highly expanded in AIM and CONV. Surprisingly, the vast majority (91%) of unique clonotypes completely disappeared following AIM and were replaced with de novo clonotypes in CONV.
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The TCR repertoire of persistent and non-persistent clonotypes in AIM, and de novo clonotypes in CONV, were examined in order to identify selection factors that governed TCR persistence. Persistent YVL TCR clonotypes maintained the major selection factors that were identified in AIM (Fig 4Aii, S2A-B) . Although some features were maintained in all 3 TCR subsets, there were significant structural differences in these repertoires. Specifically, persistent clonotypes used significantly more of the shorter 9-mer CDR3α and more of 10-, 11-, and 12-mer CDR3β than the non-persistent. In contrast, the de novo clonotypes favored 12-mer CDR3α and 11-mer CDR3β length (Fig 3Bi-ii) .
Non-persistent CDR3α clonotypes used AV8.1 but it was paired with many more AJ gene families (Fig S2A) . Moreover, AV8.1-VKDTDK-AJ34 clonotypes, which were present in 42±20% or 19±11% of all persistent clonotypes during AIM or CONV, respectively, were present in the non-persistent response at a much lower mean frequency (6±1%; Fig 4Aii, Table S4A -B). The clonal composition of the CDR3β nonpersistent response varied greatly in BV usage between donors and lacked identifiable motifs, suggesting that for YVL clones expressing AV8.1-VKDTDK-AJ34 to persist, there are some preferential if not obvious TCRβ motifs.
For de novo clonotypes, new selection factors appeared that may relate to either a decrease in antigen expression or a change in antigen-expressing cells over the course of persistent infection. For instance, in the YVL 9-mer de novo clonotypes, the selection factor AV8.1-AJ34 was maintained in 2/3 donors and a new modified motif, VKNTDK was identified (Fig 4Aii, S2Ai) . The de novo 11-mer CDR3α response had increased usage of AV12 in all 3 donors (Fig S2Aii) . In de novo BV clonotypes, the pattern of BV-BJ usage changed compared to that observed in AIM. Similarly, de novo 13-mer CDR3β clonotypes were also totally different with usage of a new motif, SALLGX, in 2/3 donors (Table S4C) .
Within the GLC TCR repertoire, significant changes in TCR CDR3 length (Fig 3Biii-iv) were observed over time. The persistent clonotypes preferentially used 9-and 11-mer CDR3α while de novo preferred longer 12-and 14-mer lengths. The persistent clonotypes also preferentially used 11-and 13-mer CDR3β, while de novo preferred 12-mer lengths. The persistent GLC TCRα clonotypes maintained the major selection criteria that were identified in AIM with the 9-mer EDNNA motif, which strongly associated with AV5-1-AJ31, being present in a mean 5±3.7% or 10±8.6% of all persistent clonotypes during AIM or CONV, respectively, in all 3 donors (Fig 4Bii, Table   S4D ). The fact that clonotypes using this motif were not present in non-persistent clonotypes suggests that this motif, and not just the gene family, may be important in determining persistence of GLC-specific clonotypes. The persistent GLC-repertoire also maintained the major selection criteria that were identified in AIM, with the 11-mer SARD motif that strongly associated with BV20. was still a preferential usage by 2/3 donors of AV5.1 (Fig S3Ai) and the appearance in 2/3 donors of a new 11-mer CDR3α motif "ELDGQ", which associated with AV5.1-AJ16.1 (Fig 4Bii, Table S4F ). De novo clonotypes were also diverse and private using uncommon BV like BV7, BV3 but also using common BV families such as BV20 ( Fig   S3B) expressing the SARD motif in 5%±2.9 of de novo clonotypes (Fig 4Bii) .
In conclusion, the persistent clonotypes made up the vast majority of the AIM and CONV responses. For the most part, the non-persistent clonotypes did not have a motif despite the observation that some of them used a public AV or BV; this suggests that one of the strongest selection factors was the CDR3 motif. Additionally, the fact that persistent clonotypes retained features that were identified in AIM further supports their validity. Altogether, these results suggest that YVL-and GLC-specific structure drives selection of dominant persistent clonotypes while diversity is replaced but maintained.
Single-cell paired TCRαβ sequencing confirms that selection of the YVL-specific repertoire is mainly driven by TCRα while GLC-specific repertoire selection is driven by unique combinations of TCRα/β: Single-cell TCR sequencing allows examination of TCRα/β pairing and gives even more accurate information on the structural constraints of pMHC/TCR interactions although it provides only limited information on TCR repertoire diversity. Circos plot analysis of AV-BV pairing of YVLspecific TCRs in AIM and CONV showed that the TCRα repertoire was more restricted while TCRβ was diverse. As suggested by the deep sequencing data, AV8.1 paired with a multitude of BV genes (most pronounced in E1651 and E1655) (Fig 5A, C Table   S5A ). In GLC responses, there was less diversity and a conserved public AV5.1-BV20.1
pairing was present in all donors (Fig 5B, D Table S5B ).
TCRα/β pairing was further characterized by examining the pattern of gene segment usage by ribbon plots, correlating gene usage within and across TCRα/β, quantifying preferential gene usage and CDR3 motif 9 (Fig 6) . The results were combined from the 4 individuals by time point and epitope specificity. In AIM and CONV, the AV YVLrepertoire was focused on AV8.1, while the BV repertoire was highly diverse (Fig 6A) .
The public and dominant AV8.1 used by YVL-specific TCRs preferentially combined with AJ34 and yet did not display any strong preference for any particular BV, and BJ (Fig 6A) . In contrast, both the TCRα/β GLC-repertoires were more focused and characterized by a very dominant gene combination involving AV5.1/AJ31/BV20.1/BJ1 (Fig 6A) . Jensen-Shannon divergence analysis used to quantify the total magnitude of gene preference confirmed that while GLC-specific TCRs showed a strong preferential usage of particular AV and BV, YVL-specific TCRs only had a strong preference for particular AV (Fig 6B) . Quantification of the degree of gene usage co-variation between pairs of segments using the adjusted mutual information score revealed that GLCspecific TCRs displayed a high stringency, every TCR gene combination except for two in AIM (AV-AJ and AV-BJ pairings) and one in CONV (AV-BJ) were important for selection into the repertoire (Fig 6C) . In contrast, no obvious gene associations emerged for YVL-specific TCR in AIM, whereas only the AV-AJ association emerged as important in CONV for selection into the TCR repertoire (Fig 6C) . CDR3α and β motif analysis at the single cell level demonstrated similar findings to those observed from deep-sequencing (Fig 6D) . In summary, single-cell analysis complemented deepsequencing analysis by providing direct evidence that the stringency for selection into either EBV-epitope specific TCR-repertoire differed greatly. Only very particular TCRAV (which could pair with multiple different TCRBV) was required to be selected into the YVL-specific TCR-repertoire, whereas very particular pairing of TCRAV and BV, with just the right J regions are required to be selected into GLC-specific TCR-repertoire.
Structural features support the role of Vα in selection of the YVL-specific TCR repertoire: We determined the crystal structure of the HLA-A2/YVL complex in order to identify specific structural features that might be associated with the dominant TRAV and TRAJ usage in the YVL-specific TCRs (Fig 6E) . Structure determination was complicated initially by the relatively low resolution (Table S6 ) and high degree of translational pseudosymmetry (Fig S4A-D) that characterized the HLA-A2/YVL crystals (see Methods), but ultimately clear and continuous electron density extending the full length of the peptide allowed confident location of all peptide atoms (Fig S4E-F) . In the HLA-A2 complex, the nonameric YVL peptide is bound in conventional orientation, with the amino terminus and side chains of valine at position 2 and valine at position 9 accommodated in pockets (A, B, and F, respectively) in the peptide binding site.
Notably, the side chains of tyrosine at position 1, highly negative charged aspartic acid at position 4, and histidine at position 5 project away from the binding site, and compose a highly featured surface positioned for recognition by CDRα loops of a TCR bound in conventional orientation (Fig 6E) . By contrast, the side chains of leucine at position 6, isoleucine at position 7, and valine at position 8, together with exposed main-chain atoms, present a rather non-descript generally hydrophobic surface positioned to interact with CDRβ loops. This structure would predict that positively charged Lys(K)/Arg(R) in the highly dominant YVL-specific TCRα motifs (Fig 6D) might be important for recognizing the asp(D) at position 5.
Discussion
This is the first study to undertake a comprehensive longitudinal investigation of both the TCRα and β repertoires to two different epitope-specific CD8 T-cell responses in the context of a primary human EBV infection. Here, we show that each epitope drives the selection of highly diverse repertoires, that vary greatly between donors, but each epitope selects for distinct dominant clones with public features that persist into convalescence. These persistent clonotypes have distinct features specific to each antigen that appear to drive their selection; they account for only 9% of unique clonotypes, but predominate in acute infection and convalescence, accounting for 57%±4 of the total epitope-specific response. Surprisingly, the other 91% of highly diverse unique clonotypes disappear following AIM and are replaced in convalescence by equally diverse "de-novo" clonotypes (43% + 5% of the total response). The selection of unique public TCR repertoire features for each epitope in clones that dominate and persist suggest that these clones may be the best fit TCR to recognize each epitope. In contrast, the broad repertoire of unique clonotypes that are activated in AIM during high viral load and increased inflammation may not fit as well and perhaps do not receive a TCR signal that leads to survival into memory. Interestingly, 6 months after the initial infection, a completely new (de novo) and similarly diverse TCR repertoire has expanded. This may be due to continued antigenic exposure in persistent EBV infection.
Earlier studies using similar techniques to study the influenza A (IAV) HLA-A*02:01-restricted IAV-M1 58-67 and the cytomegalovirus (CMV)-pp65 epitope-specific memory responses showed a similar focused diversity structure in TCR repertoire, suggesting that this is a general principle of antigen-specific repertoire structure 27, 28 . Altogether, these studies suggest that the pMHC structure drives selection of the particular public These studies have also uncovered a role for TCRα-driven selection of the YVLrepertoire (Fig 6) . To the best of our knowledge, this is the first study to describe a TCRα-driven selection of viral epitope-specific TCRs. AV8.1 was a public gene family, dominating the conserved 9-mer response, with an obligate pairing with AJ34, and a predominant CDR3 motif "VKDTDK", representing 42% and 19% of the total persistent response in AIM and CONV, respectively. In contrast, the BV response was highly diverse without evidence of a strong selection factor, suggesting that AV8.1-VKDTDK-AJ34 could pair with multiple different BV and still successfully be selected by YVL/MHC as seen in the single cell paring data (Table S5A) . Unlike YVL, the selection of GLC- and TRBV (B) in total HLA-A2/YVL-specific TCR-repertoire is shown in pie charts (i).
The pie plots are labeled with gene families having a frequency ≥ 10% (dominant, underlined) or between 5% and 10% (subdominant; not underlined). The total numbers of unique clonotypes in each donor is shown below the pie charts. There is consistent usage of AV8 and AV12 genes in all 3 donors in both the primary and memory phases.
(ii) circos plots depicting V-J gene pairing and (iii) CDR3 motif analysis for the clonotypes with the two most dominant CDR3 lengths. Circos plots are only shown for the memory phase (AIM circos plots in Fig S1A) . 
Materials and Methods
Study population
Four 
Flow cytometry and isolation of GLC-and YVL-specific CD8 T-cells
The percentages of peripheral blood antigen-specific CD8 T-cells were measured using flow cytometry analysis. Antibodies included: anti-CD3-FITC, anti-CD4-AF700 and anti-CD8-BV786, 7AAD and PE-conjugated HLA-A*02:01-peptide tetramers (BRLF-1:
YVLDHLIVV; BMLF-1: GLCTLVAML). Tetramers were made and underwent quality assurance, as previously described 
Single-cell paired TCRαβ analysis of EBV-specific CD8 T-cells
To examine TCRα and TCRβ pairing relationships, we conducted an ex vivo single-cell analysis of the paired TCRαβ repertoire of YVL-and GLC-specific CD8 T-cells from
PBMCs of the 3 donors we have discussed thus far and one additional donor (E1651) in AIM and CONV. Following single-cell sorting, amplification of paired CDR3α and CDR3β regions was performed as previously described 57 by multiplex-nested reverse transcriptase PCR, followed by Sanger sequencing of TCRα and TCRβ products.
Sequences (see Table S5) Reactions were run in duplicate. B cell counts in each sample were determined using a 1 previously described PCR assay to quantify the copy number of the gene encoding CCR5 (two copies per diploid cell) 59 . Samples were normalized to B cell counts and EBV DNA copy number was calculated as DNA copy per 10 6 B cells.
Soluble HLA-A2/YVL protein production and crystallization.
Soluble HLA-A2/YVL complexes were prepared by folding urea-solubilized bacteriallyexpressed inclusion bodies of HLA-A2 heavy chain and human 2-microglobin in the presence of 5mg/L synthetic YVL peptide essentially as described 
HLA-A2/YVL Structure determination and refinement
Diffraction data extending to ~ 3.2Å collected from a single crystal were integrated and indexed using Mosflm Fig S4A) , and the data were reindexed in a P2 1 unit cell (189.9 x 100.2 x 292.4 Å, β =94.4°). The newly identified spots comprise the k=2n+1 and h+(k/2)=2n+1 sets (Supplemental Fig S4) . Additional molecular replacement, symmetry considerations, and examination of composite-omit maps calculated using CCP4i 63 identified 20 copies of HLA-A2 per asymmetric unit (Supplemental Fig S4B) . The molecules are arranged in two layers viewed looking into the ac plane (Supplemental Fig S4C) ; slight differences can be observed between these layers, and between similarly oriented molecules within the same layer (Supplemental Fig S4D) . These differences, along with four molecules (A,J,K,T) not identified in the C2 cell, explain the lower symmetry and strong translational pseudosymmetry that resulted in weak intensities for the k=2n+1 and h+(k/2)=2n+1 spots. After identification of the correct crystallographic and non-crystallographic symmetries, clear electron density covering all peptide atoms was observed in 20-fold averaged composite omit maps (Supplemental Fig S4E) , and a model for the YVL peptide was built using Coot
64
. Refinement using Phenix 65 proceeded smoothly despite the relatively low resolution when dihedral restraints to a higher-resolution reference model were provided. Models for the YVL peptide, which was not included in the reference model restraints, did not vary significantly between the non-crystallographically related copies (Supplemental Fig   S4F) . was used for all statistical analyses.
Data Availability
Raw TCR deep sequencing data can be accessed at:
https://urldefense.proofpoint.com/v2/url?u=http-3A__clients.adaptivebiotech.com&d=DwQGaQ&c=WJBj9sUF1mbpVIAf3biu3CPHX4Me
RjY_w4DerPlOmhQ&r=p6IL5ohbVyB2IGgNCmdbh-
A5IMFqxKtq0WBpidjH1QE&m=hueuAoY7ZXzP9YMFmhGPKpu9iLorr5nv05XTqQklDuI &s=AdlhcrGwYqZ-QWYlQON5AJFRO88HSQe1qPUMaWRkQik&e=
The login information is as follows: 
